Torthaí cuardaigh - Plummer, Ruth

Poly(ADP-ribose) polymerase inhibition: a new direction for BRCA and triple-negative breast cancer? de réir Plummer, Ruth

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Cancer immunotherapy and its potential cardiac complications de réir Findlay, Simon G, Plummer, Ruth, Plummer, Chris

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Tremelimumab-Induced Graves Hyperthyroidism de réir Gan, Earn H., Mitchell, Anna L., Plummer, Ruth, Pearce, Simon, Perros, Petros

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

mTORC1 and DNA‐PKcs as novel molecular determinants of sensitivity to Chk1 inhibition de réir Massey, Andrew J., Stephens, Peter, Rawlinson, Rebecca, McGurk, Lauren, Plummer, Ruth, Curtin, Nicola J.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Phase 1 dose-escalation study of the PARP inhibitor CEP-9722 as monotherapy or in combination with temozolomide in patients with solid tumors de réir Plummer, Ruth, Stephens, Peter, Aissat-Daudigny, Louiza, Cambois, Anne, Moachon, Gilbert, Brown, Peter D., Campone, Mario

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Mechanisms of Chemoresistance in Malignant Glioma de réir Sarkaria, Jann N., Kitange, Gaspar J., James, C. David, Plummer, Ruth, Calvert, Hilary, Weller, Michael, Wick, Wolfgang

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours de réir Ameratunga, Malaka, Braña, Irene, Bono, Petri, Postel-Vinay, Sophie, Plummer, Ruth, Aspegren, John, Korjamo, Timo, Snapir, Amir, de Bono, Johann S

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours:... de réir Cranston, Amy, Stocken, Deborah D., Stamp, Elaine, Roblin, David, Hamlin, Julia, Langtry, James, Plummer, Ruth, Ashworth, Alan, Burn, John, Rajan, Neil

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Pharmacokinetics of carfilzomib in patients with advanced malignancies and varying degrees of hepatic impairment: an open-label, single-arm, phase 1 study de réir Brown, Jennifer, Plummer, Ruth, Bauer, Todd M., Anthony, Stephen, Sarantopoulos, John, De Vos, Filip, White, Mike, Schupp, Marco, Ou, Ying, Vaishampayan, Ulka

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Phase 1 study of the ATR inhibitor berzosertib in combination with cisplatin in patients with advanced solid tumours de réir Shapiro, Geoffrey I., Wesolowski, Robert, Devoe, Craig, Lord, Simon, Pollard, John, Hendriks, Bart S., Falk, Martin, Diaz-Padilla, Ivan, Plummer, Ruth, Yap, Timothy A.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Phase 1 study of the ATR inhibitor berzosertib (formerly M6620, VX-970) combined with gemcitabine ± cisplatin in patients with advanced solid tumours de réir Middleton, Mark R., Dean, Emma, Evans, Thomas R. J., Shapiro, Geoffrey I., Pollard, John, Hendriks, Bart S., Falk, Martin, Diaz-Padilla, Ivan, Plummer, Ruth

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Targeting the DNA Double Strand Break Repair Machinery in Prostate Cancer de réir Shaheen, Fadhel S., Znojek, Pawel, Fisher, Ann, Webster, Martin, Plummer, Ruth, Gaughan, Luke, Smith, Graeme C. M., Leung, Hing Y., Curtin, Nicola J., Robson, Craig N.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors de réir Plummer, Ruth, Madi, Ayman, Jeffels, Melinda, Richly, Heike, Nokay, Bahar, Rubin, Stephen, Ball, Howard A., Weller, Steve, Botbyl, Jeffrey, Gibson, Diana M., Scheulen, Max E.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

A case of malignant hyperlactaemic acidosis appearing upon treatment with the mono-carboxylase transporter 1 inhibitor AZD3965 de réir McNeillis, Rosie, Greystoke, Alastair, Walton, Jon, Bacon, Chris, Keun, Hector, Siskos, Alexandros, Petrides, George, Leech, Nicola, Jenkinson, Fiona, Bowron, Ann, Halford, Sarah, Plummer, Ruth

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Correction: A case of malignant hyperlactaemic acidosis appearing upon treatment with the mono-carboxylase transporter 1 inhibitor AZD3965 de réir McNeillis, Rosie, Greystoke, Alastair, Walton, Jon, Bacon, Chris, Keun, Hector, Siskos, Alexandros, Petrides, George, Leech, Nicola, Jenkinson, Fiona, Bowron, Ann, Halford, Sarah, Plummer, Ruth

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Selumetinib in combination with dexamethasone for the treatment of relapsed/refractory RAS-pathway mutated paediatric and adult acute lymphoblastic leukaemia (SeluDex): study proto... de réir Menne, Tobias, Slade, Daniel, Savage, Joshua, Johnson, Sarah, Irving, Julie, Kearns, Pamela, Plummer, Ruth, Shenton, Geoff, Veal, Gareth J, Vormoor, Britta, Vormoor, Josef, Billingham, Lucinda

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

A phase 1b/2, open-label, dose-escalation, and dose-confirmation study of eribulin mesilate in combination with capecitabine de réir Twelves, Chris, Anthoney, Alan, Savulsky, Claudio I., Guo, Matthew, Reyderman, Larisa, Cresti, Nicola, Semiglazov, Vladimir, Timcheva, Constanta, Zubairi, Ishtiaq, Morrison, Rosemary, Plummer, Ruth, Evans, T. R. Jeffry

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

A phase I study of intravenous and oral rucaparib in combination with chemotherapy in patients with advanced solid tumours de réir Wilson, Richard H, Evans, TR Jeffry, Middleton, Mark R, Molife, L Rhoda, Spicer, James, Dieras, Veronique, Roxburgh, Patricia, Giordano, Heidi, Jaw-Tsai, Sarah, Goble, Sandra, Plummer, Ruth

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

SARS-CoV-2 vaccination and phase 1 cancer clinical trials de réir Yap, Timothy A, Siu, Lillian L, Calvo, Emiliano, Lolkema, Martijn P, LoRusso, Patricia M, Soria, Jean-Charles, Plummer, Ruth, de Bono, Johann S, Tabernero, Josep, Banerji, Udai

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

First-in-human study of the PARP/tankyrase inhibitor E7449 in patients with advanced solid tumours and evaluation of a novel drug-response predictor de réir Plummer, Ruth, Dua, Divyanshu, Cresti, Nicola, Drew, Yvette, Stephens, Peter, Foegh, Marie, Knudsen, Steen, Sachdev, Pallavi, Mistry, Bipin M., Dixit, Vaishali, McGonigle, Sharon, Hall, Nancy, Matijevic, Mark, McGrath, Shannon, Sarker, Debashis

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán